1-11 of 11
HG Klingemann
Close
Sort by
Journal Articles

Purging of malignant cells from blood after short ex vivo incubation with NK-92 cells [letter; comment]

HG Klingemann, B Miyagawa
Journal: Blood
Blood (1996) 87 (11): 4913–4914.
https://doi.org/10.1182/blood.V87.11.4913.bloodjournal87114913
Published: 1996
Journal Articles

High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy

DE Reece, MJ Barnett, JD Shepherd, DE Hogge, RJ Klasa, SH Nantel, HJ Sutherland, HG Klingemann, RN Fairey, NJ Voss
Journal: Blood
Blood (1995) 86 (2): 451–456.
https://doi.org/10.1182/blood.V86.2.451.bloodjournal862451
Published: 1995
Journal Articles

Transfer of the tumor necrosis factor alpha gene into hematopoietic progenitor cells as a model for site-specific cytokine delivery after marrow transplantation

T Kuhr, GJ Dougherty, HG Klingemann
Journal: Blood
Blood (1994) 84 (9): 2966–2970.
https://doi.org/10.1182/blood.V84.9.2966.2966
Published: 1994
Journal Articles

Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study [see comments]

MJ Barnett, CJ Eaves, GL Phillips, RD Gascoyne, DE Hogge, DE Horsman, RK Humphries, HG Klingemann, PM Lansdorp, SH Nantel
Journal: Blood
Blood (1994) 84 (3): 724–732.
https://doi.org/10.1182/blood.V84.3.724.724
Published: 1994
Journal Articles

Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]

DE Reece, JM Connors, JJ Spinelli, MJ Barnett, RN Fairey, HG Klingemann, SH Nantel, S O'Reilly, JD Shepherd, HJ Sutherland
Journal: Blood
Blood (1994) 83 (5): 1193–1199.
https://doi.org/10.1182/blood.V83.5.1193.1193
Published: 1994
Journal Articles

Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected] [published erratum appears in Blood 1992 Jun 15;79(12):3397]

HG Klingemann, AP Grigg, K Wilkie-Boyd, MJ Barnett, AC Eaves, DE Reece, JD Shepherd, GL Phillips
Journal: Blood
Blood (1991) 78 (12): 3306–3311.
https://doi.org/10.1182/blood.V78.12.3306.3306
Published: 1991
Journal Articles

High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults

GL Phillips, DE Reece, JD Shepherd, MJ Barnett, RA Brown, DA Frei-Lahr, HG Klingemann, BJ Bolwell, JJ Spinelli, RH Herzig
Journal: Blood
Blood (1991) 77 (7): 1429–1435.
https://doi.org/10.1182/blood.V77.7.1429.1429
Published: 1991
Journal Articles

Detection of breakpoint cluster region- negative and nonclonal hematopoiesis in vitro and in vivo after transplantation of cells selected in cultures of chronic myeloid leukemia marrow

AG Turhan, RK Humphries, CJ Eaves, MJ Barnett, GL Phillips, DK Kalousek, HG Klingemann, PL Lansdorp, DE Reece, JD Shepherd
Journal: Blood
Blood (1990) 76 (11): 2404–2410.
https://doi.org/10.1182/blood.V76.11.2404.2404
Published: 1990
Journal Articles

Distribution of integrins on human peripheral blood mononuclear cells

HG Klingemann, S Dedhar
Journal: Blood
Blood (1989) 74 (4): 1348–1354.
https://doi.org/10.1182/blood.V74.4.1348.1348
Published: 1989
Journal Articles

Inhibition of prostaglandin E2 restores defective lymphocyte proliferation and cell-mediated lympholysis in recipients after allogeneic marrow grafting

HG Klingemann, MS Tsoi, R Storb
Journal: Blood
Blood (1986) 68 (1): 102–107.
https://doi.org/10.1182/blood.V68.1.102.102
Published: 1986
Journal Articles

Bone marrow transplantation in patients aged 45 years and older

HG Klingemann, R Storb, A Fefer, HJ Deeg, FR Appelbaum, CD Buckner, MA Cheever, PD Greenberg, PS Stewart, KM Sullivan
Journal: Blood
Blood (1986) 67 (3): 770–776.
https://doi.org/10.1182/blood.V67.3.770.770
Published: 1986